0000950123-22-002162.txt : 20220211
0000950123-22-002162.hdr.sgml : 20220211
20220211163718
ACCESSION NUMBER: 0000950123-22-002162
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220211
DATE AS OF CHANGE: 20220211
EFFECTIVENESS DATE: 20220211
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioImpact Capital LLC
CENTRAL INDEX KEY: 0001687078
IRS NUMBER: 364818254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20107
FILM NUMBER: 22621805
BUSINESS ADDRESS:
STREET 1: 450 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6174259200
MAIL ADDRESS:
STREET 1: 450 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: MPM Oncology Impact Management LP
DATE OF NAME CHANGE: 20161007
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001687078
XXXXXXXX
12-31-2021
12-31-2021
false
BIOIMPACT CAPITAL LLC
450 KENDALL STREET
CAMBRIDGE
MA
02142
13F HOLDINGS REPORT
028-20107
Y
The securities reported herein include securities previously included in the Form 13F filings of Burrage Capital Management LLC (File No. 028-20040), as Bioimpact Capital LLC acquired the assets of Burrage Capital Management LLC after June 30, 2021.
Ansbert Gadicke
Member
(617) 425-9200
/s/Ansbert Gadicke
Cambridge
MA
02-11-2022
0
33
548527
false
INFORMATION TABLE
2
10206.xml
INFORMATION TABLE FOR FORM 13F
Acadia Pharmaceuticals Inc
Common
004225108
2918
125000
SH
SOLE
125000
0
0
ADC Therapeutics, Inc.
Common
H0036K147
6815
337396
SH
SOLE
337396
0
0
Amicus Therapeutics Inc.
Common
03152W109
5929
513333
SH
SOLE
513333
0
0
Avadel Pharmaceuticals Plc
Common
05337M104
3033
375326
SH
SOLE
375326
0
0
AVROBIO, Inc.
Common
05455M100
2494
647918
SH
SOLE
647918
0
0
Axsome Therapeutics Inc.
Common
05464T104
3907
103405
SH
SOLE
103405
0
0
Biocryst Pharmaceuticals Inc.
Common
09058V103
9168
661951
SH
SOLE
661951
0
0
Black Diamond Therapeutics, Inc.
Common
09203E105
1279
239888
SH
SOLE
239888
0
0
Crinetics Pharmaceuticals Inc.
Common
22663K107
10790
379792
SH
SOLE
379792
0
0
Cullinan Oncology, Inc.
Common
230031106
118013
7648268
SH
SOLE
7648268
0
0
Cytokinetics Inc.
Common
23282W605
10587
232268
SH
SOLE
232268
0
0
Epizyme, Inc.
Common
29428V104
8563
3425202
SH
SOLE
3425202
0
0
ESSA Pharma, Inc.
Common
29668H708
9495
668688
SH
SOLE
668688
0
0
G1 Therapeutics, Inc.
Common
3621LQ109
8748
856798
SH
SOLE
856798
0
0
Geron Corporation
Common
374163103
6861
5623889
SH
SOLE
5623889
0
0
Harmony Biosciences Hldgs Inc.
Common
413197104
6074
142437
SH
SOLE
142437
0
0
Harpoon Therapeutics, Inc.
Common
41358P106
24135
3196707
SH
SOLE
3196707
0
0
Inozyme Pharma Inc.
Common
45790W108
2064
302615
SH
SOLE
302615
0
0
Intellia Therapeutics, Inc.
Common
45826J105
18981
160527
SH
SOLE
160527
0
0
iTeos Therapeutics, Inc.
Common
46565G104
85890
1844727
SH
SOLE
1844727
0
0
MEI Pharma, Inc.
Common
55279B202
32977
12350971
SH
SOLE
12350971
0
0
Merus N.V.
Common
N5749R100
29488
927302
SH
SOLE
927302
0
0
Mirum Pharmaceuticals Inc.
Common
604749101
4767
298852
SH
SOLE
298852
0
0
Neogenomics Inc.
Common
64049M209
4791
140422
SH
SOLE
140422
0
0
Oncorus, Inc.
Common
68236R103
12527
2377031
SH
SOLE
2377031
0
0
Repare Therapeutics, Inc.
Common
760273102
34584
1639849
SH
SOLE
1639849
0
0
Revolution Medicines, Inc.
Common
76155X100
3676
146041
SH
SOLE
146041
0
0
TCR2 Therapeutics, Inc.
Common
87808K106
15709
3370982
SH
SOLE
3370982
0
0
Travere Therapeutics Inc.
Common
89422G107
8936
287893
SH
SOLE
287893
0
0
Turning Point Therapeutics, Inc.
Common
90041T108
12943
271350
SH
SOLE
271350
0
0
Verastem, Inc.
Common
92337C104
6707
3271532
SH
SOLE
3271532
0
0
Werewolf Therapeutics, Inc.
Common
95075A107
28441
2388011
SH
SOLE
2388011
0
0
YmAbs Therapeutics, Inc.
Common
984241109
7237
446457
SH
SOLE
446457
0
0